icon-    folder.gif   Conference Reports for NATAP  
 
  (APASL) 23rd Conference of the Asian Pacific
Association for the Study of the Liver
6-9 June
2013, Singapore
Back grey_arrow_rt.gif
 
 
 
No Detectable Tenofovir Resistance With Tenofovir Disoproxil Fumarate (TDF) or TDF+Emtricitabine (FTC/TDF) Through 96 Weeks in Lamivudine-Resistant CHB Patients
 
 
  Reported by Jules Levin
Asian Pacific Association for the Study of the Liver (APASL) Liver Week, June 6-10, 2013, Singapore
 
Edward Gane1, Amoreena C. Corsa2, Yang Liu2, Ben C. Mitchell2, John F. Flaherty2,
Michael D. Miller2, Kathryn M. Kitrinos2, Scott Fung3 1New Zealand Liver Transplant Unit, Auckland, New Zealand; 2Gilead Sciences, Inc., Foster City, CA, USA; 3Toronto General Hospital, Toronto, Ontario, Canada

APASL1.gif

APASL2.gif

APASL3.gif

APASL4.gif

APASL5.gif

APASL6.gif

APASL7.gif

APASL8.gif